Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M24.3Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-1.7
Enterprise Value $M3.2EPS (TTM) $-1.8Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.4Pre-tax Margin (%)--Higher ROA y-yY
Price/Book1.110-y EBITDA Growth Rate %-51.1Quick Ratio9.0Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-41.1Current Ratio9.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-50.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-54.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M9.2ROIC % (ttm)-703.9Gross Margin Increase y-yN

Gurus Latest Trades with ABIO

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ABIO is held by these investors:



ABIO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ozeroff Christopher DavidS.V.P., General Counsel 2017-04-04Sell418$2.419.96view
Keuer Thomas ACOO 2017-04-04Sell390$2.419.96view
BRISTOW MICHAEL RPres. & Chief Executive Offic 2017-04-04Sell720$2.419.96view
Selby Brian L.VP, Finance 2017-04-03Sell1,114$2.467.72view
CONWAY ROBERT EDirector 2017-03-24Buy25,000$2.592.32view
Ozeroff Christopher DavidS.V.P., General Counsel 2017-02-28Sell465$2.611.53view
Keuer Thomas ACOO 2017-02-28Sell465$2.611.53view
BRISTOW MICHAEL RPres. & Chief Executive Offic 2017-02-28Sell763$2.611.53view
Selby Brian L.VP, Finance 2017-02-27Sell161$2.563.52view
Keuer Thomas ACOO 2016-10-18Sell483$2.458.16view

Quarterly/Annual Reports about ABIO:

News about ABIO:

Articles On GuruFocus.com
ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Nov 15 2010 
ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Aug 10 2010 
ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) May 10 2010 
ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Nov 16 2009 
ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Aug 10 2009 
ARCA biopharma Inc. Reports Operating Results (10-Q) May 15 2009 
ARCA biopharma Inc. Reports Operating Results (10-Q) Feb 07 2009 

More From Other Websites
ARCA biopharma Announces 200th Patient Randomized into the GENETIC-AF Seamless Design Phase 2B/3... Apr 26 2017
ARCA biopharma to Present at the Planet MicroCap Showcase 2017 Investor Conference Apr 18 2017
ARCA biopharma Announces Fiscal Year 2016 Financial Results and Provides Business Update Mar 21 2017
ARCA biopharma Announces 175th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial Mar 06 2017
Anders Hove, MD Joins ARCA biopharma Board of Directors Feb 21 2017
ARCA biopharma to Present at Biotech Showcase 2017 Jan 04 2017
StockNewsNow.com Publishes New SNNLive Video Interview with ARCA biopharma, Inc. Provides Company... Nov 15 2016
ARCA biopharma Announces Third Quarter 2016 Financial Results and Provides Business Update Nov 14 2016
ARCA biopharma Announces Randomization of First European Patients in GENETIC-AF Phase 2B/3 Clinical... Oct 06 2016
ARCA biopharma Named Winner of Corporate LiveWire Healthcare and Lifesciences Innovation Award Sep 13 2016
ARCA biopharma Announces Second Quarter 2016 Financial Results and Provides Business Update Aug 09 2016
Albioma :ABIO-FR: Earnings Analysis: For the six months ended June 30, 2016 : August 3, 2016 Aug 03 2016
ARCA biopharma Announces First Quarter 2016 Financial Results and Provides Business Update May 11 2016
Bearish case for Valeant Mar 17 2016
Applying Lessons from KBIO Dec 08 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)